Back to Trials
NCT05128890Recruiting

Evaluation of Resection Techniques for Pancreatic Tumors

Methodist Health System

Start Date

4/16/2016

Completion Date

4/26/2027

Summary

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Detailed Description

The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older Exclusion Criteria: * Patients that have not undergone pancreatic resection surgeries * Patients under 18 years of age

Interventions

PROCEDURE

Resection techniques for pancreatic and liver tumors

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

SurgeryLiver TumorPancreas Tumor

Locations

Methodist Dallas Medical Center

Dallas, Texas 75203

United States